- Home
- LOCL vs TPST Comparison
LOCL vs TPST Comparison
Compare LOCL & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCL
- TPST
- Stock Information
- Founded
- LOCL 2021
- TPST 2011
- Country
- LOCL United States
- TPST United States
- Employees
- LOCL N/A
- TPST N/A
- Industry
- LOCL Farming/Seeds/Milling
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- LOCL Consumer Staples
- TPST Health Care
- Exchange
- LOCL Nasdaq
- TPST Nasdaq
- Market Cap
- LOCL 55.8M
- TPST 45.5M
- IPO Year
- LOCL N/A
- TPST N/A
- Fundamental
- Price
- LOCL $2.18
- TPST $9.92
- Analyst Decision
- LOCL
- TPST Hold
- Analyst Count
- LOCL 0
- TPST 3
- Target Price
- LOCL N/A
- TPST $30.00
- AVG Volume (30 Days)
- LOCL 15.8K
- TPST 60.6K
- Earning Date
- LOCL 11-13-2025
- TPST 11-11-2025
- Dividend Yield
- LOCL N/A
- TPST N/A
- EPS Growth
- LOCL N/A
- TPST N/A
- EPS
- LOCL N/A
- TPST N/A
- Revenue
- LOCL $44,020,000.00
- TPST N/A
- Revenue This Year
- LOCL $42.28
- TPST N/A
- Revenue Next Year
- LOCL $78.57
- TPST N/A
- P/E Ratio
- LOCL N/A
- TPST N/A
- Revenue Growth
- LOCL 39.74
- TPST N/A
- 52 Week Low
- LOCL $1.18
- TPST $5.35
- 52 Week High
- LOCL $5.75
- TPST $20.67
- Technical
- Relative Strength Index (RSI)
- LOCL 39.97
- TPST 51.47
- Support Level
- LOCL $2.09
- TPST $9.90
- Resistance Level
- LOCL $2.31
- TPST $11.02
- Average True Range (ATR)
- LOCL 0.18
- TPST 0.66
- MACD
- LOCL -0.01
- TPST -0.14
- Stochastic Oscillator
- LOCL 37.10
- TPST 22.34
About LOCL Local Bounti Corporation
Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.